National Vision Holdings Revenue 2015-2020 | EYE

National Vision Holdings revenue from 2015 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
National Vision Holdings Annual Revenue
(Millions of US $)
2019 $1,724
2018 $1,537
2017 $1,375
2016 $1,196
2015 $1,063
2014 $933
National Vision Holdings Quarterly Revenue
(Millions of US $)
2020-03-31 $470
2019-12-31 $402
2019-09-30 $432
2019-06-30 $429
2019-03-31 $461
2018-12-31 $356
2018-09-30 $387
2018-06-30 $386
2018-03-31 $408
2017-12-31 $322
2017-09-30 $346
2017-06-30 $338
2017-03-31 $370
2016-12-31
2016-09-30 $301
2015-12-31
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.127B $1.724B
National Vision Holdings, Inc. is involved in optical retail primarily in the United States. The company offer product and services for eye care needs through retail stores and consumer websites. Its brand portfolio consists of America's Best Contacts & Eyeglasses, Eyeglass World, Vision Centers inside select Walmart stores and Vista Optical locations inside Fred Meyer stores and on select military bases. National Vision Holdings, Inc. is headquartered in Duluth, Georgia.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $162.911B 28.25
Medtronic (MDT) Ireland $131.524B 21.38
Stryker (SYK) United States $73.223B 23.76
Boston Scientific (BSX) United States $52.434B 24.65
Baxter (BAX) United States $44.736B 27.31
Lonza Group Ag (LZAGY) Switzerland $36.436B 0.00
Terumo (TRUMY) Japan $29.523B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.846B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.418B 16.62
ResMed (RMD) United States $22.976B 36.26
Smith & Nephew SNATS (SNN) United Kingdom $18.348B 0.00
Sunny Optical Technology (SNPTF) China $14.583B 0.00
Bio-Rad Laboratories (BIO) United States $14.145B 64.39
Insulet (PODD) United States $11.644B 1153.63
DiaSorin S.p.A (DSRLF) Italy $10.630B 0.00
Canopy Growth (CGC) Canada $7.619B 0.00
Perrigo (PRGO) Ireland $7.501B 13.42
Shandong Weigao Medical Polymer (SHWGF) China $7.281B 0.00
Quidel (QDEL) United States $7.023B 55.19
Hill-Rom Holdings (HRC) United States $6.867B 19.36
William Demant Holdings (WILYY) Denmark $6.670B 0.00
GN STORE NORD (GNNDY) Denmark $6.590B 34.05
Haemonetics (HAE) United States $5.562B 33.41
ICU Medical (ICUI) United States $4.105B 29.95
GW Pharmaceuticals (GWPH) United Kingdom $3.879B 0.00
Neogen (NEOG) United States $3.702B 62.71
Agios Pharmaceuticals (AGIO) United States $3.675B 0.00
Envista Holdings (NVST) United States $3.334B 0.00
NuVasive (NUVA) United States $3.147B 25.27
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.829B 0.00
TG Therapeutics (TGTX) United States $2.175B 0.00
AtriCure (ATRC) United States $1.946B 0.00
Aurora Cannabis (ACB) Canada $1.556B 0.00
Cardiovascular Systems (CSII) United States $1.386B 0.00
Aphria (APHA) Canada $1.152B 0.00
NanoString Technologies (NSTG) United States $1.134B 0.00
MacroGenics (MGNX) United States $1.130B 0.00
Phibro Animal Health (PAHC) United States $1.088B 21.69
Cerus (CERS) United States $0.997B 0.00
InMode (INMD) Israel $0.915B 19.33
PetIQ (PETQ) United States $0.863B 24.93
OraSure Technologies (OSUR) United States $0.839B 168.88
Omeros (OMER) United States $0.826B 0.00
Quanterix (QTRX) United States $0.764B 0.00
VAREX IMAGING (VREX) United States $0.741B 18.39
DFB Healthcare Acquisitions (AHCO) United States $0.738B 124.92
Eagle Pharmaceuticals (EGRX) United States $0.711B 50.90
Zynex (ZYXI) United States $0.628B 63.10
Meridian Bioscience (VIVO) United States $0.607B 22.87
Lantheus Holdings (LNTH) United States $0.569B 11.44
LeMaitre Vascular (LMAT) United States $0.546B 31.10
Vapotherm (VAPO) United States $0.541B 0.00
Surmodics (SRDX) United States $0.524B 63.13
Owens & Minor (OMI) United States $0.488B 12.92
Repro-Med Systems (KRMD) United States $0.379B 318.33
Utah Medical Products (UTMD) United States $0.365B 26.50
Cytosorbents (CTSO) United States $0.350B 0.00
BioLife Solutions (BLFS) United States $0.340B 151.09
Organigram Holdings (OGI) Canada $0.329B 0.00
Viemed Healthcare (VMD) United States $0.308B 27.59
Neptune Wellness Solutions (NEPT) Canada $0.280B 0.00
HEXO (HEXO) $0.278B 0.00
Female Health (VERU) United States $0.247B 0.00
InfuSystems Holdings (INFU) United States $0.219B 121.22
Chimerix (CMRX) United States $0.197B 0.00
Evolus (EOLS) United States $0.179B 0.00
Chembio Diagnostics (CEMI) United States $0.157B 0.00
Fonar (FONR) United States $0.154B 13.63
Bovie Medical (APYX) United States $0.151B 0.00
Rockwell Medical (RMTI) United States $0.148B 0.00
Exagen (XGN) United States $0.146B 0.00
Surface Oncology (SURF) United States $0.138B 0.00
MTech Acquisition (KERN) United States $0.137B 0.00
Liberty Health Sciences (LHSIF) Canada $0.135B 0.00
United Health Products (UEEC) United States $0.133B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.115B 0.00
Brainsway (BWAY) Israel $0.085B 0.00
Wound Management Technologies (SMTI) United States $0.078B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.076B 0.00
United-Guardian (UG) United States $0.076B 17.51
Nephros (NEPH) United States $0.070B 0.00
Capricor Therapeutics (CAPR) United States $0.062B 0.00
GUARDION HEALTH (GHSI) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.031B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
NF Energy Saving (BIMI) China $0.025B 0.00
FSD PHARMA INC (HUGE) Canada $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Myomo (MYO) United States $0.011B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00